HFA Premium Access

SCD and ventricular event rates in a Japanese population: Primary results from the Heart Failure Indication and Sudden Cardiac Death Prevention Trial

Topic: Epidemiology, Prognosis, Outcome

Presentation

About the speaker

Doctor Kazutaka Aonuma

Tsukuba (Japan)
1 presentation
0 follower

10 more presentations in this session

Clinical course and related costs of patients with type 2 diabetes and heart failure and/or chronic kidney disease, drawn from a sample of more than 7 million people

Speaker: Professor A. Maggioni (Florence, IT)

Thumbnail

Potential Implications of Expanded FDA Labeling for Sacubitril/Valsartan in the United States

Speaker: Doctor M. Vaduganathan (Boston, US)

Thumbnail

Prescription Fill Patterns of Guideline-Directed Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States

Speaker: Doctor M. Vaduganathan (Boston, US)

Thumbnail

Higher Alkaline Phosphatase Mean and Variability Predict Heart Failure and All-cause Mortality

Speaker: Ms S. Lee (Hong Kong, CN)

Thumbnail

Heart Failure Drug Titration, Discontinuation and Mortality and HF Hospitalization Risk: A Multinational Observational Study (US, UK and Sweden)

Speaker: Associate Professor G. Savarese (Stockholm, SE)

Thumbnail

Access the full session

Registry Updates

Speakers: Doctor K. Aonuma, Professor A. Maggioni, Doctor M. Vaduganathan, Doctor M. Vaduganathan, Ms S. Lee...
Thumbnail

About the event

Image

Heart Failure 2021 Online Congress

29 June - 1 July 2021

Sessions Presentations

This platform is supported by

logo Novo Nordisk